192 related articles for article (PubMed ID: 30170359)
1. Exploring the conformational behaviour and aggregation properties of lipid-conjugated AS1411 aptamers.
Riccardi C; Musumeci D; Russo Krauss I; Piccolo M; Irace C; Paduano L; Montesarchio D
Int J Biol Macromol; 2018 Oct; 118(Pt B):1384-1399. PubMed ID: 30170359
[TBL] [Abstract][Full Text] [Related]
2. AS1411 derivatives as carriers of G-quadruplex ligands for cervical cancer cells.
Figueiredo J; Lopes-Nunes J; Carvalho J; Antunes F; Ribeiro M; Campello MPC; Paulo A; Paiva A; Salgado GF; Queiroz JA; Mergny JL; Cruz C
Int J Pharm; 2019 Sep; 568():118511. PubMed ID: 31301466
[TBL] [Abstract][Full Text] [Related]
3. Toward G-Quadruplex-Based Anticancer Agents: Biophysical and Biological Studies of Novel AS1411 Derivatives.
Ogloblina AM; Iaccarino N; Capasso D; Di Gaetano S; Garzarella EU; Dolinnaya NG; Yakubovskaya MG; Pagano B; Amato J; Randazzo A
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096752
[TBL] [Abstract][Full Text] [Related]
4. Aptamer-based Targeted Delivery of a G-quadruplex Ligand in Cervical Cancer Cells.
Carvalho J; Paiva A; Cabral Campello MP; Paulo A; Mergny JL; Salgado GF; Queiroz JA; Cruz C
Sci Rep; 2019 May; 9(1):7945. PubMed ID: 31138870
[TBL] [Abstract][Full Text] [Related]
5. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
Mosafer J; Mokhtarzadeh A
Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
[TBL] [Abstract][Full Text] [Related]
6. Bioactivity of 2'-deoxyinosine-incorporated aptamer AS1411.
Fan X; Sun L; Wu Y; Zhang L; Yang Z
Sci Rep; 2016 May; 6():25799. PubMed ID: 27194215
[TBL] [Abstract][Full Text] [Related]
7. G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: Uses and mechanisms.
Bates PJ; Reyes-Reyes EM; Malik MT; Murphy EM; O'Toole MG; Trent JO
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1414-1428. PubMed ID: 28007579
[TBL] [Abstract][Full Text] [Related]
8. Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells.
Noaparast Z; Hosseinimehr SJ; Piramoon M; Abedi SM
J Drug Target; 2015; 23(6):497-505. PubMed ID: 25673264
[TBL] [Abstract][Full Text] [Related]
9. Phthalocyanines for G-quadruplex aptamers binding.
Lopes-Nunes J; Carvalho J; Figueiredo J; Ramos CIV; Lourenço LMO; Tomé JPC; Neves MGPMS; Mergny JL; Queiroz JA; Salgado GF; Cruz C
Bioorg Chem; 2020 Jul; 100():103920. PubMed ID: 32413624
[TBL] [Abstract][Full Text] [Related]
10. Binding affinity and conformation of a conjugated AS1411 aptamer at a cationic lipid bilayer interface.
Li P; Wang L; Sun M; Yao J; Li W; Lu W; Zhou Y; Zhang G; Hu C; Zheng W; Wei F
Phys Chem Chem Phys; 2022 Apr; 24(15):9018-9028. PubMed ID: 35381056
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation.
Reyes-Reyes EM; Šalipur FR; Shams M; Forsthoefel MK; Bates PJ
Mol Oncol; 2015 Aug; 9(7):1392-405. PubMed ID: 25911416
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitization of breast cancer cells using AS1411 aptamer-conjugated gold nanoparticles.
Mehrnia SS; Hashemi B; Mowla SJ; Nikkhah M; Arbabi A
Radiat Oncol; 2021 Feb; 16(1):33. PubMed ID: 33568174
[TBL] [Abstract][Full Text] [Related]
13. High affinity of AS1411 toward copper; its application in a sensitive aptasensor for copper detection.
Bahreyni A; Ramezani M; Alibolandi M; Hassanzadeh P; Abnous K; Taghdisi SM
Anal Biochem; 2019 Jun; 575():1-9. PubMed ID: 30926271
[TBL] [Abstract][Full Text] [Related]
14. Aptamer-Functionalized and Backbone Redox-Responsive Hyperbranched Polymer for Targeted Drug Delivery in Cancer Therapy.
Zhuang Y; Deng H; Su Y; He L; Wang R; Tong G; He D; Zhu X
Biomacromolecules; 2016 Jun; 17(6):2050-62. PubMed ID: 27113017
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy and cardioprotection of nucleolin-targeted doxorubicin-loaded ultrasound nanobubbles in treating triple-negative breast cancer.
Fang K; Wang L; Huang H; Dong S; Guo Y
Nanotechnology; 2021 Mar; 32(24):. PubMed ID: 33690196
[TBL] [Abstract][Full Text] [Related]
16. AS1411 aptamer modified carbon dots via polyethylenimine-assisted strategy for efficient targeted cancer cell imaging.
Kong T; Zhou R; Zhang Y; Hao L; Cai X; Zhu B
Cell Prolif; 2020 Jan; 53(1):e12713. PubMed ID: 31691382
[TBL] [Abstract][Full Text] [Related]
17. Biological studies of an ICG-tagged aptamer as drug delivery system for malignant melanoma.
Lopes-Nunes J; Lifante J; Shen Y; Ximendes EC; Jaque D; Iglesias-de la Cruz MC; Cruz C
Eur J Pharm Biopharm; 2020 Sep; 154():228-235. PubMed ID: 32707287
[TBL] [Abstract][Full Text] [Related]
18. Aptamer-guided acridine derivatives for cervical cancer.
Carvalho J; Lopes-Nunes J; Lopes AC; Cabral Campello MP; Paulo A; Queiroz JA; Cruz C
Org Biomol Chem; 2019 Mar; 17(11):2992-3002. PubMed ID: 30810582
[TBL] [Abstract][Full Text] [Related]
19. Nanoaggregate-forming lipid-conjugated AS1411 aptamer as a promising tumor-targeted delivery system of anticancer agents in vitro.
Carvalho J; Lopes-Nunes J; Vialet B; Rosado T; Gallardo E; Vale J; Eloy C; Ferreira S; Palmeira-de-Oliveira R; Campello MPC; Paulo A; Barthélémy P; Mergny JL; Salgado GF; Queiroz JA; Ellington AD; Cruz C
Nanomedicine; 2021 Aug; 36():102429. PubMed ID: 34174419
[TBL] [Abstract][Full Text] [Related]
20. AS1411 binds to nucleolin via its parallel structure and disrupts the exos-miRNA-27a-mediated reciprocal activation loop between glioma and astrocytes.
Sun X; Zhang W; Gou C; Wang X; Wang X; Shao X; Chen X; Chen Z
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167211. PubMed ID: 38701957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]